Premium
FGF‐2 Regulates Valve Interstitial Cell Repair Through TGF‐b/Smad Signaling
Author(s) -
Han Li,
Gotlieb Avrum I
Publication year - 2011
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.25.1_supplement.1000.2
Subject(s) - neutralizing antibody , fibroblast growth factor , antibody , transforming growth factor , immunohistochemistry , fibroblast , smad , microbiology and biotechnology , chemistry , medicine , immunology , in vitro , biology , receptor , biochemistry
Background Transforming growth factor‐β (TGF‐β) and fibroblast growth factor‐2 (FGF‐2) both promote valve interstitial cell (VIC) repair. The relationship between TGF‐β and FGF‐2 in wound repair is not understood. Methods VIC confluent monolayers were wounded and treated with FGF‐2, FGF‐2 neutralizing antibody, TGF‐β neutralizing antibody and/or betaglycan antibody. Phosphorylated‐Smad2/3 (pSmad2/3) was localized at the wound edge (WE). Down‐regulation of pSmad2/3 protein expression was achieved via siRNA transfection. Results FGF‐2 treatment increased the number of VICs with nuclear pSmad2/3 staining at the WE compared to nontreated WE. Treatment with TGF‐β neutralizing antibody alone or with FGF‐2 present resulted in a similar decrease in nuclear pSmad2/3. Treatment with FGF‐2 neutralizing antibody alone or with FGF‐2 present showed a similar decrease in nuclear pSmad2/3; however the effect of FGF‐2 neutralizing antibody was less than that of TGF‐β neutralizing antibody. Incubation with betaglycan antibody inhibited FGF‐2‐mediated pSmad2/3 signaling. Down‐regulation of pSmad2/3 reduced the extent to which FGF‐2 promoted wound closure. Conclusion FGF‐2 promotes in vitro VIC wound repair, at least in part, through the TGF‐β/Smad2/3 signaling pathway. Supported by the Heart and Stroke Foundation of Ontario (grant NA6204) and the Canadian Institutes for Health Research (grant 84228).